This is an interdisciplinary program that will train specialists working at the intersection of IT, medicine, and biology. The first 20 students will be admitted in September 2025 for a 6-year program.
Three students talked about the technopark, its medical division, and flagship project that will help to treat breast cancer.
Rodion Ivashchenko, one of the founders of the Olympiad and a student at the Zelman Institute explained how the Olympiad became a global event in only two years.
A new "Pharmacy" specialization, continuing teaching medical sciences to foreign students, engaging students and scientists in research in specialized laboratories of the new ZIMP building – Head of ZIMP NSU Andrey Pokrovsky talked about strategic plans with the correspondent.
Foreign students at the V. Zelman Institute of Medicine and Psychology graduated with degrees in General Medicine. In 2016, they were the first students to come from Egypt, Syria, Iraq, and other countries to study medicine at ÌìÃÀmv.
The world's first in vivo study of large mammals using the Boron Neutron Capture Therapy (BNCT) accelerator is a major step towards human clinical trials.
Coronavirus infection can cause a threat of early termination of pregnancy, exacerbate kidney and bladder infections, and provoke the development of gestational diabetes mellitus (increased blood glucose levels during pregnancy).
It is related to the clinical trials of new drugs used to regulate and restore brain activity. University invites volunteers aged 40 to 85 years who suffer from stage I-II cerebral ischemia.
The immediate influence of the research is changing the routine practice of anesthesiologists-resuscitators in the diagnosis and prevention of perioperative myocardial infarction. In the future, the data obtained will make it possible to determine a new, higher limit for the troponin level.
The search for new pharmacophores for uracil-DNA-glycosylase inhibitors will make it possible to develop drugs to reduce the virulence of bacterial and viral diseases, as well as to increase the effectiveness of treatment for oncological and autoimmune diseases. A study by Novosibirsk scientists published their work on this topic in the journal «Molecules».
By the agreement between the NSU’s V. Zelman Institute for Medicine and Psychology (ZIMP) and the Siberian Register of Bone Marrow Donors, any resident in the Novosibirsk Region can donate biomaterial and become a potential bone marrow donor.